Nymirum

Nymirum

Nymirum

Nymirum is a venturebacked, privately held drug discovery company that has developed a proprietary platform that allows RNA to be targeted by small molecules.
Founded
2009
Raised
$550k
Follow us
Alexa global traffic share
Latest funding
$550,000
Venture capital - 2009
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Nymirum makes some noise.